Podcasts about neurometrix

S&P futures are indicating a slightly higher open, up +0.11% as investors await the Federal Reserve's rate decision later today. Markets expect a 25 bps rate cut, with keen attention on the accompanying dot plot and Chair Powell's commentary, particularly regarding the Fed's outlook for 2025 rate adjustments. In Asia, Nissan and Honda are reportedly in merger talks, accelerating due to interest from Hon Hai Precision. European focus is on UK inflation data, with headline CPI accelerating in November as expected, though core and services inflation surprised on the downside. Companies Mentioned: Nissan, Honda, Cousins Properties, NeuroMetrix

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, February 16, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Sparrow BioAcoustics launched software that turns a smartphone into a stethoscope. Fast Five hosts Sean Whooley and Danielle Kirsh talk about how the software works and the visualizations it gives physicians. Medtronic has named its first chief sustainable officer. Find out who is taking on this newly created role. Enable Injections is expanding its manufacturing facilities to support drug delivery device production. Whooley explains the expansion effort and how it fits into the strategy of the company. The FDA cleared Merit Medical's surgical guidance system. Learn what the guidance system does and how it improves patient care. NeuroMetrix announced plans to review its strategic options. The Fast Five hosts explain what the company is considering and if there will be any changes to its commercial operations.

Disclaimer: Intended audience is the US Healthcare Providers only. These podcasts are not a substitute for medical advice and/or services from a healthcare provider. These podcasts may not be relied upon in any way in connection with your personal health care related decisions and treatment. All such decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs. Kenneth Snow is Senior Director Medical Affairs. His responsibilities include the development and review of research studies to provide clinical evidence in support of Insulet's products. Prior to joining Insulet, Dr. Snow was Product Strategy Medical Director in the Pharmacy Services Section of CVS Health and served as Medical Director for Clinical Trial Services overseeing research projects for external clients with attention to analytical results and clinical conclusions. Prior to joining CVSHealth, Dr. Snow was Chief Medical Officer for NeuroMetrix, a medical device company involved in the diagnosis and treatment of diabetic neuropathy. Previously, Dr. Snow was on the staff of the Joslin Diabetes Center in Boston for 19 years including 5 years as Chief of the Adult Diabetes Section. In addition, he was an Assistant Professor of Clinical Medicine at Harvard Medical School. Dr. Snow attended MIT and Johns Hopkins School of Medicine. He did his internship and residency in Internal Medicine at Northwestern Memorial Hospitals in Chicago and his fellowship in Endocrinology at the New England Medical Center Hospitals in Boston. He received his MBA from the University of Massachusetts.

In this week's DeviceTalks Weekly podcast, Outset Medical's Leslie Trigg recounts the career detour that led her to a successful career in medical devices. Drawing on past experiences, the CEO explains why she chose to lead Outset's mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset's “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches. Chris Newmarker delivers another stellar Newmarker's Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical. Subscribe on all major podcast channels.

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pin" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

During the third episode of BrainSplain, your host, Kaitlyn Rarick connects with the Founder and CEO of NeuroMetrix, Shai Gozani M.D., Ph.D. Electroceuticals are a new type of therapeutic agents that work by mapping neural circuitry and delivering neural impulses to these specific targets. Listen to find out more about the impact and future of electroceuticals.  Shai Gozani Short Bio Shai Gozani, founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. He currently serves as Chairman of the board of directors and as our President and Chief Executive Officer. Shai has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Over 2.5 million patients have benefited from the Company's technology over the past 17 years. Shai has published over 30 peer-reviewed scientific articles and has been awarded 25 US and international patents. He holds a B.A. degree in Computer Science, a M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology, from the University of California, Berkeley. Shai also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T. Links https://www.neurometrix.com/ (NeuroMetrix Website) https://www.quellrelief.com/ (Quell Relief Website) Kaitlyn Rarick https://www.linkedin.com/in/kaitlyn-rarick-90176b169/ (LinkedIn)

On this week’s Tech Nation, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

On this week’s Tech Nation, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

On this week’s Tech Nation Health, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

Leveraging on digital technologies to address health care problems

On this week’s Tech Nation, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

On this week’s Tech Nation, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

On this week’s Tech Nation, Moira speaks with we’re talking about pain. Podiatric surgeon Dr. David Armstrong, a Professor of Surgery at the Keck School of Medicine at USC, and Davide Vigano, CEO of Sensoria, talk about the long term effect of diabetes on the feet, and how to prevent and help heal problems. Dr. Shai Gozani, the President and CEO of NeuroMetrix, talks about their solution for treating chronic pain, and a study of pain sufferers in the face of the opioid crisis.

1) AAN guideline summary: Treatment of restless legs syndrome in adults 2) What's Trending: Interview with Dr. Steven Messé on why acute ischemic stroke patients are not receiving IV tPA3) Topic of the month: Neurology Today story about cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out forThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Fullard interviews Dr. John Winkelman about the AAN guideline summary on the treatment of restless legs syndrome in adults. Dr. Andy Southerland is interviewing Dr. Steven Messé for our “What's Trending” feature of the week about his paper on why are acute ischemic stroke patients not receiving IV tPA. In the next part of the podcast Dr. Ted Burns interviews Drs. Kevin Messacar and Ken Tyler about a Neurology Today story on the topic on cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out for.DISCLOSURES: Dr. Winkelman serves as Associate Editor for Sleep; serves as an editorial board member of Sleep Medicine and CNS Drugs; received honoraria from serving on the scientific advisory board of Merck Serono, Flex Pharma, UCB, Impax Pharmaceuticals, Pfizer Inc, Lacrima, Luitpold Pharmaceuticals, GlaxoSmithKline, Boehringer Ingelheim, Xenoport, Zeo Inc., Sunovion, Insys, Takeda Pharmaceutical Company Limited, Jazz and Neurogen; receives royalties from the publication of the books: Foundations of Psychiatric Sleep Medicine and Nocturnal Leg Cramps; holds stock options in Flex Pharma; provided expert witness work for ArentFox and CantorColburn; received funding for travel from Novartis and Otsuka; currently performs neurophysiology studies as part of his practice;receives research support from Xenoport, GlaxoSmithKline, UCB, Sepracor, Pfizer Inc, Impax Pharmaceuticals, Purdue, Neurometrix and the NIH.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.Dr. Messé received publishing royalties from UpToDate; received compensation from GlaxoSmithKline for consulting on protocol development for a trial of a neuroprotectant in high risk surgery; received research support from GlaxoSmithKline, Bayer Schering Pharma, WL Gore and the NIH.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Tyler serves as an Associate Editor for Journal of Neurovirology and Neurology Today; serves as an editorial board member for Annals of Neurology, Apoptosis, JAMA Neurology, Experimental Neurology, Journal of Infectious Disease, Microbial Pathogenesis, Virology, Neurology ALL Current; serves on the scientific advisory board for PML Consortium; is a consultant for Hoffman La Roche; receives royalties from the publication of the books: Handbook of Clinical Neurology and Harrison's Principles & Practices of Internal Medicine; receives research support from the NIH. All other participants report no disclosures.